13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001664974
Total reported value
$78.6M
$78.6M
5 檔
165.4%
At the close of Q2 2025, Data Collective IV GP, LLC disclosed equity holdings valued at approximately $78.6M, spread across 5 reported holdings.
Data Collective IV GP, LLC executed strategic sector rebalancing during Q2 2025, establishing 1 new positions while fully exiting 1 holdings and trimming 0 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | EVLV | Evolv Technologies Holdings | Stock-Other | 46.50% | -15.74% | — | |
| 2 | RKLB | Rocket Lab CORP | Stock-Industrials | 29.82% | — | — | |
| 3 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 23.14% | -4.84% | — | |
| 4 | BRD1EUR | Mind Medicine Mindmed Inc | Stock-Other | 0.50% | — | — | |
| 5 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RKLB | Rocket Lab CORP | +29.8% | NEW | New buy |
| 2 | EVLV | Evolv Technologies Holdings | +11.7% | — | Unchanged |
| 3 | ROIV | Roivant Sciences Ltd. | 0% | — | Unchanged |
| 4 | BRD1EUR | Mind Medicine Mindmed Inc | -0.2% | — | Unchanged |
| 5 | RXRX | Recursion Pharmaceuticals-a | -13% | — | Unchanged |
| 6 | RKLB | Rocket Lab Corporation | -28.4% | EXIT | Sold out |
According to official SEC Form 13F filings, Data Collective IV GP, LLC reported a total U.S. public equity portfolio value of $78.6M across 5 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including EVLV, RKLB, RXRX) accounted for 165.4% of total reported equity market value during Q2 2025.
Top New Position Initiated
RKLB
市值: $38.7M
Top Position Liquidated / Trimmed
RKLB
前期市值: $24.6M
During Q2 2025, Data Collective IV GP, LLC's top holdings by market value included EVLV (46.5%)、RKLB (29.8%)、RXRX (23.1%). The largest single position, EVLV, represented 46.5% of total portfolio value.
In Q2 2025, Data Collective IV GP, LLC made 2 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.